- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03845985
Piloting "Signs of Safety": A Deaf-Accessible Therapy Toolkit for Alcohol Use Disorder and Trauma
Study Overview
Status
Intervention / Treatment
Detailed Description
The U.S. Deaf community - 500,000+ Americans who communicate using American Sign Language (ASL) - experiences nearly triple the rate of lifetime problem drinking compared to the general population and twice the rate of trauma exposure. Although there are validated treatments for comorbid alcohol use disorder (AUD) and posttraumatic stress disorder (PTSD) in hearing populations, there are no evidence-based treatments to treat any behavioral health condition with Deaf clients. Current treatments fail to meet Deaf clients' unique linguistic and cultural needs. Deaf people's median English reading level falls at the fourth grade, and many have low health literacy due to reduced incidental learning (e.g., inability to communicate with hearing parents, overhear family conversations, or understand spoken health information on TV/radio/public service announcements). Written treatment materials, therefore, require plain text revisions, ASL translations, or ASL narrative storytelling. Equally important are materials that incorporate Deaf values and social norms, increasing clinicians' cultural competence and enhancing client engagement.
To address these barriers, the Principal Investigator conducted a pilot study to develop a prototype of "Signs of Safety": a Deaf-accessible toolkit to be used alongside a widely-disseminated protocol for addiction/PTSD - Seeking Safety. Seeking Safety has demonstrated efficacy for reduction of AUD and PTSD symptoms in hearing populations. Among available evidence-based protocols, "Seeking Safety" is the optimal choice to adapt for Deaf clients - its focus on simple coping skills that simultaneously target AUD and PTSD (or either alone) is an ideal match for Deaf people's language and learning deficits, which prohibit use of verbal problem-solving and cognitive processing strategies that other psychotherapies require. Yet, Seeking Safety's client materials rely on written English and are not well understood by Deaf clients. As such, the "Signs of Safety" toolkit includes a therapist guide and population-specific client materials (e.g., visual handouts; ASL teaching stories on digital video). It is designed for Deaf/signing clinicians, as well as non-signing clinicians working with ASL interpreters.
Data from the Principal Investigator's "Signs of Safety" single-arm pilot study (n = 13) show significant reductions in alcohol use frequency and PTSD severity from baseline to immediate post-treatment follow-up. Participants also reported high levels of satisfaction with the model, and provided detailed feedback about how to further improve "Signs of Safety" for a professional-quality, second iteration. The proposed study builds upon the Principal Investigator's pilot work by generating a final, professional iteration of Signs of Safety to be used in future efficacy work. Based on pilot results, the study team created a second iteration of the "Signs of Safety" toolkit, including re-filming ASL teaching stories, re-designing visual handouts, and revising the therapist companion guide. The study team will then develop a training program for "Signs of Safety" and certify four study clinicians.
The study team proposes to conduct a two-arm pilot RCT of "Signs of Safety". The study team aims to enroll 60 Deaf adults with past-month PTSD and past-month alcohol consumption to participate in 12 weekly individual treatment sessions. The pilot RCT will compare the 12-session protocol of Seeking Safety + "Signs of Safety" toolkit with an assessment-only waitlist control. Across conditions, assessment will occur at baseline, week 4, week 8, immediate post-treatment/week 12, and one-month follow-up/week 16. The study team will analyze key aspects of feasibility for both study arms (e.g., recruitment, retention, assessment process). Primary clinical outcomes at immediate post-treatment and one-month follow-up are past 30-day alcohol use frequency/quantity and past 30-day PTSD severity. Exploratory analyses will be conducted to examine potential moderators and mediators of change (e.g., motivation for treatment, provider cultural competency, coping skills, self-compassion, understanding of health information) leading to positive outcome. Results from this study will produce feasibility and preliminary efficacy data to support for a full-scale RCT to evaluate "Signs of Safety", and a community-engaged model for conducting RCTs with Deaf participants.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01655
- University of Massachusetts Medical School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Self-identification as a Deaf ASL user
- Age 18 or older
- Past-month alcohol consumption, as measured by the Alcohol Use Disorder Identification Test
- Subthreshold or full PTSD on the PTSD Checklist for DSM-5 (past-month referent time period; "subthreshold" = endorsement of at least two B-E criteria at a severity of "moderate" or higher)
- Ability to attend weekly study sessions at one of three study locations (Eastern, Central, or Western MA)
- Ability to access a videophone (the standard telecommunication device for the Deaf community)
Exclusion Criteria:
- Participation in concurrent therapies (Note: Participants in both study conditions will be asked to refrain from concurrent formal psychotherapy; however, aligning with the Seeking Safety model, AA/NA/DRA attendance will be encouraged and attendance will be tracked as a potential outcome mediator).
- Members of the following special populations: Adults unable to consent; Individuals younger than 18; Prisoners; Pregnant women (Note: We will not knowingly include pregnant women as participants; however, we will not assess participants' pregnancy status.)
Exclusion criteria are intentionally minimal to recruit a diverse sample. Other behavioral health comorbidities (e.g., mood/anxiety disorders, substance use disorders other than AUD) will not be excluded, given high rates of comorbidity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Seeking Safety + Signs of Safety toolkit
Participants randomized to receive the intervention will be provided 12 one-hour weekly individual treatment sessions with one of four ASL-fluent study clinicians in Massachusetts.
Assessments will occur at baseline, week 4, week 8, immediate post-treatment/week 12, and one-month follow-up/week 16.
|
Seeking Safety is an existing, present-focused, first-stage manualized treatment for trauma and addiction. Session content engages clients in themes relevant to addiction and trauma, and to help them learn a specific skill to target symptoms of both AUD and PTSD (e.g., "Coping with Triggers," "Asking for Help"). "Signs of Safety" is a culturally and linguistically Deaf-accessible toolkit to be used alongside Seeking Safety. The toolkit includes a therapist guide and population-specific client materials (e.g., visual handouts; ASL teaching stories on digital video). It is designed for Deaf/signing clinicians, as well as non-signing clinicians working with ASL interpreters. |
No Intervention: Assessment-only Waitlist Control
Participants randomized to the waitlist control condition will be offered the opportunity to receive the 12-session Seeking Safety + Signs of Safety toolkit intervention after an approximate 16 week waiting period.
This 16 week waiting period is equivalent to the current waitlist to receive psychotherapy services through the PI's outpatient clinic.
Assessments will occur at baseline, week 4, week 8, immediate post-treatment/week 12, and one-month follow-up/week 16.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline Percent Drinking Days Per Month at Immediate Post-Treatment
Time Frame: Change from baseline to immediate post-intervention at 12 weeks
|
Change from baseline percent drinking days per month (i.e., days with 1+ drink) at immediate post-intervention or 12 weeks as assessed by Alcohol Timeline Followback
|
Change from baseline to immediate post-intervention at 12 weeks
|
Change From Baseline Percent Drinking Days Per Month at One-month Follow-up
Time Frame: Change from baseline to one-month follow-up at 16 weeks
|
Change from baseline percent drinking days per month (i.e., days with 1+ drink) at one-month follow-up or 16 weeks as assessed by Alcohol Timeline Followback
|
Change from baseline to one-month follow-up at 16 weeks
|
Change From Baseline Percent Binge Drinking Days Per Month at Immediate Post-Treatment
Time Frame: Change from baseline to immediate post-intervention at 12 weeks
|
Change from baseline percent binge drinking days per month (i.e., days with 5+ drinks for men, 4+ for women) at immediate post-intervention or 12 weeks as assessed by Alcohol Timeline Followback
|
Change from baseline to immediate post-intervention at 12 weeks
|
Change From Baseline Percent Binge Drinking Days Per Month at One-month Follow-up
Time Frame: Change from baseline to one-month follow-up at 16 weeks
|
Change from baseline percent binge drinking days per month (i.e., days with 5+ drinks for men, 4+ for women) at one-month follow-up or 16 weeks as assessed by Alcohol Timeline Followback
|
Change from baseline to one-month follow-up at 16 weeks
|
Change From Baseline Number of Drinks Per Month at Immediate Post-Treatment
Time Frame: Change from baseline to immediate post-intervention at 12 weeks
|
Change from baseline number of drinks per month at immediate post-treatment or 12 weeks as assessed by Alcohol Timeline Followback
|
Change from baseline to immediate post-intervention at 12 weeks
|
Change From Baseline Number of Drinks Per Month at One-month Follow-up
Time Frame: Change from baseline to one-month follow-up at 16 weeks
|
Change from baseline number of drinks per month at one-month follow-up or 16 weeks as assessed by Alcohol Timeline Followback
|
Change from baseline to one-month follow-up at 16 weeks
|
Change From Baseline Past 30-day PTSD Severity to Immediate Post-Treatment as Assessed by PCL-5
Time Frame: Change from baseline to immediate post-intervention at 12 weeks
|
Total Score on the PCL-5 divided by 20 items.
Minimum score = 0; Maximum score = 4. Higher values represent more severe symptoms of PTSD.
|
Change from baseline to immediate post-intervention at 12 weeks
|
Change From Baseline Past 30-day PTSD Severity at One-month Follow-up as Assessed by PCL-5
Time Frame: Change from baseline to one-month follow-up at 16 weeks
|
Total Score on the PCL-5 divided by 20 items.
Minimum score = 0; Maximum score = 4. Higher values represent more severe symptoms of PTSD.
|
Change from baseline to one-month follow-up at 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Brief Comprehensive Effects of Alcohol Questionnaire (B-CEOA)
Time Frame: Baseline/Pre-intervention, Week 4, Week 8, Week 12/Post-intervention, and Week 16/One-month Follow-up
|
All four subscales: Min. = 1, Max. = 4. Risk and Aggression/Liquid Courage/Sociability Subscale: Higher values indicate greater outcome expectancies of drinking alcohol on risk-taking, aggression, courage, and sociability. Self-Perception/Cognitive and Behavioral Impairment Subscale: Higher values indicate greater outcome expectancies on distorted self-perception and impaired behavior. Sexuality Subscale: Higher values indicate greater outcome expectancies on sexual behavior. Tension Reduction Subscale: Higher values indicate greater outcome expectancies on tension reduction. |
Baseline/Pre-intervention, Week 4, Week 8, Week 12/Post-intervention, and Week 16/One-month Follow-up
|
Penn Alcohol Craving Scale (PACS)
Time Frame: Baseline/Pre-intervention, Week 4, Week 8, Week 12/Post-intervention, and Week 16/One-month Follow-up
|
Total score = sum of all 5 items. Minimum = 0; Maximum = 30. Higher values indicate higher severity of alcohol craving. |
Baseline/Pre-intervention, Week 4, Week 8, Week 12/Post-intervention, and Week 16/One-month Follow-up
|
Trauma Symptom Checklist - 40 (TSC-40)
Time Frame: Baseline/Pre-Intervention, Week 12/Post-Intervention, Week 16/One-month Follow-up
|
Sum of all items divided by 40 items. Minimum = 0; Maximum = 3. Higher values indicate more severe trauma symptoms. |
Baseline/Pre-Intervention, Week 12/Post-Intervention, Week 16/One-month Follow-up
|
Behavior and Symptom Identification Scale - 24 (BASIS-24)
Time Frame: Baseline/Pre-Intervention, Week 12/Post-Intervention, Week 16/One-month Follow-up
|
Sum of all items divided by 24 items.
Minimum = 0; Maximum = 4. Higher values indicate worsening behavior or more severe behavioral health symptoms.
|
Baseline/Pre-Intervention, Week 12/Post-Intervention, Week 16/One-month Follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Client Satisfaction with Treatment Sessions as Assessed by Seeking Safety End of Session Questionnaire
Time Frame: Weeks 1 - 12
|
Participants in the intervention group will complete a questionnaire at the end of each weekly therapy session to assess level of helpfulness and satisfaction with the session.
The questionnaire includes four questions (e.g., How helpful was today's session for you?) that are rated on a 4-point scale from 0 (Not at all) to 3 (A great deal), and two open-ended questions for comments and feedback on the session.
Scores range from 0-12, with higher scores indicating greater satisfaction with the session.
|
Weeks 1 - 12
|
Client Feedback on Intervention as Assessed by Seeking Safety End of Treatment Questionnaire at week 12
Time Frame: Week 12
|
Participants in the intervention group will complete a questionnaire after completing the intervention to assess level of helpfulness and satisfaction with the treatment overall.
The questionnaire uses a 7-point rating scale from -3 (Greatly harmful) to 0 (Neutral) to 3 (Greatly helpful) for questions regarding the helpfulness of the treatment and includes open-ended questions for feedback and comments.
|
Week 12
|
Client Satisfaction with Intervention as Assessed by the Client Satisfaction Questionnaire (CSQ-8) at 12 weeks
Time Frame: Week 12
|
The Client Satisfaction Questionnaire (CSQ-8) is an 8-item instrument used to assess general client satisfaction levels regarding a service.
Items are rated on a 4-point scale.
Scores are summed across items.
Items B, D, E, and H are reverse scored.
Total scores range from 8 to 32, with the higher number indicating greater satisfaction.
|
Week 12
|
Therapist Fidelity as Assessed by "Signs of Safety" Fidelity Scale
Time Frame: Weeks 4, 8, 12
|
All intervention sessions will be videotaped, with 25% (3 sessions per participant) rated for fidelity on an ongoing basis by the Fidelity Consultant.
One tape will be randomly selected from sessions 1 - 4; one from 5 - 8; and one from 9 - 12.
The session tapes will be rated using the "Signs of Safety" Fidelity Scale to assess therapist integrity with regards to the following domains: (1) Focus on Deaf experience, (2) Comparison of Deaf and hearing people's recovery, (3) Communication access, (4) Validation of Deaf experience, (5) Respect for Deaf culture, (6) Attention to body language, and (7) Attention to language.
Questions are rated on a 4-point scale with higher scores indicating greater integrity and fidelity.
|
Weeks 4, 8, 12
|
Therapist Adherence to Intervention as Assessed by Seeking Safety Adherence Scale
Time Frame: Weeks 4, 8, 12
|
All intervention sessions will be videotaped, with 25% (3 sessions per participant) rated for adherence on an ongoing basis by the Fidelity Consultant.
One tape will be randomly selected from sessions 1 - 4; one from 5 - 8; and one from 9 - 12.
The session tapes will be rated using the Seeking Safety Adherence Scale to assess adherence in three domains: (1) Format (e.g., did they clinician follow the session structure of Seeking Safety?), (2) Content (e.g., Did the clinician use the Seeking Safety content?), (3) Process (e.g., Did the clinician use strong general clinical skills?).
Questions are rated on a 4-point scale with higher scores indicating greater adherence to the intervention.
|
Weeks 4, 8, 12
|
Participant Adherence to Intervention
Time Frame: Post-Intervention at Week 12
|
Participant Adherence will be measured using the number of sessions completed, comprehension of session content, and rates of participants' treatment enactment (i.e., completing "homework" between sessions).
|
Post-Intervention at Week 12
|
Exit Interview
Time Frame: Post-Intervention and after study completion
|
Qualitative interview in which participants are asked their opinions and feedback on study design including suggested improvements for future research studies with Deaf participants.
|
Post-Intervention and after study completion
|
Collaborators and Investigators
Investigators
- Principal Investigator: Melissa L Anderson, PhD, University of Massachusetts, Worcester
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H00016364
- R34AA026929 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Traumatic Stress Disorder
-
University of California, Los AngelesDefense Advanced Research Projects Agency; Defense Group, Inc.CompletedPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder, ChronicUnited States
-
Weill Medical College of Cornell UniversityCompletedPost-traumatic Stress Disorder | Complex Post-Traumatic Stress DisorderUnited States
-
University of California, Los AngelesRecruitingPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder in ChildrenUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPost-Traumatic Stress Disorder in Children | Post-Traumatic Stress Disorder in AdolescenceUnited States
-
University of ZurichCompletedPost Traumatic Stress Disorder (PTSD) | Complex Post-Traumatic Stress Disorder (CPTSD)Switzerland
-
University of NottinghamNottinghamshire Healthcare NHS Trust; Lincolnshire Partnership NHS Foundation...CompletedDomestic Violence | Trauma, Psychological | Post-Traumatic Stress Disorder in Children | Narrative Exposure Therapy | Post-Traumatic Stress Disorder in Adolescence | Post-Traumatic Stress Disorder ComplexUnited Kingdom
-
Praxis Precision MedicinesTerminatedStress Disorders, Post-Traumatic | Trauma and Stressor Related Disorders | Post Traumatic Stress Disorder | Stress Disorder | Post-traumatic Stress Disorder | Mental DisorderUnited States
-
University Hospital, LilleNot yet recruiting
-
Steinn SteingrimssonRecruiting
-
Direction Centrale du Service de Santé des ArméesRecruitingPost-traumatic Stress DisorderFrance
Clinical Trials on Seeking Safety + Signs of Safety toolkit
-
University of Massachusetts, WorcesterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingPTSD | Alcohol; Use, Problem
-
University of New MexicoPatient-Centered Outcomes Research InstituteCompletedSubstance Use Disorders | Post-Traumatic Stress DisorderUnited States
-
University of Massachusetts, WorcesterHealth Resources and Services Administration (HRSA)CompletedPosttraumatic Stress Disorder
-
VA Office of Research and DevelopmentCompletedSubstance Use Disorders | Posttraumatic Stress DisorderUnited States
-
University of North Carolina, Chapel HillCompleted
-
US Department of Veterans AffairsBoston Medical CenterCompleted
-
VA Boston Healthcare SystemCompletedSubstance Use Disorder | Posttraumatic Stress Disorder | Alcohol Use DisorderUnited States
-
University of WindsorUniversity of Manitoba; Treatment Innovations; Manitoba Gambling Research ProgramCompletedPosttraumatic Stress Disorder | Gambling Disorder | Trauma, Psychological | Problem GamblingUnited States
-
Health Sciences North Research InstituteNorth Shore Tribal CouncilCompletedSubstance Use Disorders | Post-Traumatic Stress Disorder | Intergenerational TraumaCanada
-
University of MiamiCompleted